EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sevoflurane Suppresses Cardiomyocyte Pyroptosis in Myocardial Ischemia via NLRP3 Inflammasome Signaling

Mingjing Feng, Lingling Zheng, Baozeng Chen, Huijian Shi iD

Analytical Cellular Pathology · 2025

DOI: 10.1155/ancp/7119597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Cellular Pathology, 2025. Verfasst von Mingjing Feng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second People's Hospital of Liaocheng, Liaocheng, Shandong, China. Hauptthemen laut MEDLINE: Pyroptosis, NLR Family, Pyrin Domain-Containing 3 Protein, Sevoflurane, Inflammasomes. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical and Health Science and Technology Development Project of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The purpose of this study was to investigate the impact of sevoflurane (SEV) on cardiomyocyte (CM) pyroptosis following myocardial ischemia (MI). Reverse validation was performed by pharmacologically activating NLRP3 with monosodium urate (MSU) to confirm that SEV’s cardioprotective effects were specifically mediated through the NLRP3 inflammasome pathway. Sprague Dawley rats were randomly assigned to sham (sham), model (conventional anesthesia + MI‐reperfusion [MIR] injury modeling), SEV (SEV inhalation anesthesia + MIR injury modeling), and SEV + NLRP3 (SEV inhalation anesthesia + MIR injury modeling + NLRP3) groups. The myocardial area at risk (MAAR) and the myocardial infarct size (MIS) were evaluated in each experimental group, and cardiac tissue was examined using hematoxylin‐eosin (H&E), Masson trichrome, and TUNEL staining. The concentrations of creatine kinase‐MB (CK‐MB), cardiac troponin I (cTnI), oxidative stress (OS), and pyroptosis‐associated proteins and various inflammatory markers in the serum and cardiac tissue were quantified. Results showed that compared to the sham group, both model and SEV groups exhibited a significant increase in MAAR and MIS, accompanied by severe histopathological damage and noticeable OS ( p < 0.05). Elevated levels of inflammatory factors, enhanced CM apoptosis, and increased expression of pyroptosis‐associated proteins were also observed in these groups. Notably, the SEV intervention in the SEV group demonstrated evident mitigation of heart injury, reduced MAAR and MIS, diminished CM apoptosis and inflammatory factors, and suppressed pyroptosis‐associated proteins. Additionally, we observed that NLRP3 activation significantly diminished the protective effects of SEV on MIR rats. This study uncovers a novel mechanism through which SEV suppresses CM pyroptosis by inhibiting NLRP3, as confirmed by pharmacological activation of NLRP3. This was evidenced by worsened histopathological damage, increased CM apoptosis, and higher levels of inflammatory factors, cardiac injury markers, and pyroptosis‐associated proteins. Overall, SEV inhibits CM pyroptosis and mitigates OS and inflammation through the NLRP3 inflammasome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisNLR Family, Pyrin Domain-Containing 3 ProteinSevofluraneInflammasomesMyocytes, CardiacSignal TransductionMyocardial IschemiaAnimalsRats, Sprague-DawleyMaleRatsOxidative StressMyocardial Reperfusion Injury

Stichwörter der Autor:innen

NLRP3 inflammatory vesiclescardiomyocytesmyocardial ischemiapyroptosissevoflurane

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinSevofluraneInflammasomesNlrp3 protein, rat

Autor:innen und Institutionen

  • Department of Anesthesiology, The Second People's Hospital of Liaocheng, Liaocheng, Shandong, China.
  • Department of Cardiology, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
  • Department of Cardiology, The Second People's Hospital of Liaocheng, Liaocheng, Shandong, China.
  • Department of Anesthesiology, The Second Affiliated Hospital of Shandong First Medical University, Shandong, Jinan, China.

ORCID-Profile: Huijian Shi

Förderung

  • Medical and Health Science and Technology Development Project of Shandong Province

Zitieren

APA

Feng, M., Zheng, L., Chen, B., & Shi, H. (2025). Sevoflurane Suppresses Cardiomyocyte Pyroptosis in Myocardial Ischemia via NLRP3 Inflammasome Signaling. Analytical Cellular Pathology. https://doi.org/10.1155/ancp/7119597

Vancouver

Feng M, Zheng L, Chen B, Shi H. Sevoflurane Suppresses Cardiomyocyte Pyroptosis in Myocardial Ischemia via NLRP3 Inflammasome Signaling. Analytical Cellular Pathology. 2025. doi:10.1155/ancp/7119597

BibTeX
@article{Feng2025,
  author = {Feng, Mingjing and Zheng, Lingling and Chen, Baozeng and Shi, Huijian},
  title = {Sevoflurane Suppresses Cardiomyocyte Pyroptosis in Myocardial Ischemia via NLRP3 Inflammasome Signaling},
  journal = {Analytical Cellular Pathology},
  year = {2025},
  doi = {10.1155/ancp/7119597}
}
Kostenlos starten →